{"id":"NCT02371759","sponsor":"University of Belgrade","briefTitle":"Lidocaine + Clonidine for Intraoral Anesthesia in Patients With Diabetes Mellitus Type 2","officialTitle":"Efficacy and Safety of Intraoral Local Anesthesia by Lidocaine + Clonidine in Patients With Diabetes Mellitus Type 2","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-06","primaryCompletion":"2016-01","completion":"2016-01","firstPosted":"2015-02-26","resultsPosted":"2017-05-03","lastUpdate":"2017-05-03"},"enrollment":256,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Diabetes Mellitus","Local Anesthesia"],"interventions":[{"type":"DRUG","name":"L+C maxillary anesthesia","otherNames":[]},{"type":"DRUG","name":"L+C mandibular anesthesia","otherNames":[]},{"type":"DRUG","name":"L+E maxillary anesthesia","otherNames":[]},{"type":"DRUG","name":"L+E mandibular anesthesia","otherNames":[]}],"arms":[{"label":"Diabetics: L+C maxillary anesthesia","type":"EXPERIMENTAL"},{"label":"Diabetics: L+C mandibular anesthesia","type":"EXPERIMENTAL"},{"label":"Diabetics: L+E maxillary anesthesia","type":"ACTIVE_COMPARATOR"},{"label":"Diabetics: L+E mandibular anesthesia","type":"ACTIVE_COMPARATOR"},{"label":"Healthy: L+C maxillary anesthesia","type":"EXPERIMENTAL"},{"label":"Healthy: L+C mandibular anesthesia","type":"EXPERIMENTAL"},{"label":"Healthy: L+E maxillary anesthesia","type":"ACTIVE_COMPARATOR"},{"label":"Healthy: L+E mandibular anesthesia","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to determine whether 2% lidocaine (L) + clonidine (C) (15 mcg/ml) as a vasoconstrictor achieves efficient (equal or better parameters of intraoral local anesthesia in comparison to 2% lidocaine + epinephrine (E) (1:80 000)) and safe (stable cardiovascular parameters - systolic, diastolic, mean blood pressure and heart rate) intraoral local anesthesia in patients with Diabetes mellitus type 2.","primaryOutcome":{"measure":"Duration of Intraoral Local Anesthesia","timeFrame":"Up to 6 hours after local anesthesia injection","effectByArm":[{"arm":"Diabetics: L+C Maxillary Anesthesia","deltaMin":132.48,"sd":91.86},{"arm":"Diabetics: L+C Mandibular Anesthesia","deltaMin":173.27,"sd":70.44},{"arm":"Diabetics: L+E Maxillary Anesthesia","deltaMin":182.09,"sd":57.86},{"arm":"Diabetics: L+E Mandibular Anesthesia","deltaMin":195.35,"sd":68.99},{"arm":"Healthy: L+C Maxillary Anesthesia","deltaMin":108.82,"sd":27.76},{"arm":"Healthy: L+C Mandibular Anesthesia","deltaMin":155.59,"sd":60.75},{"arm":"Healthy: L+E Maxillary Anesthesia","deltaMin":114.74,"sd":39.72},{"arm":"Healthy: L+E Mandibular Anesthesia","deltaMin":172.91,"sd":68.93}],"pValues":[{"comp":"OG000 vs OG001 vs OG002 vs OG003 vs OG004 vs OG005 vs OG006 vs OG007","p":"<0.05"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":6},"locations":{"siteCount":1,"countries":["Serbia"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":29},"commonTop":[]}}